Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells

[1]  Yan-ming Sun,et al.  KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. , 2010, Biochemical and biophysical research communications.

[2]  V. D’Agata,et al.  PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells , 2010, Neuropeptides.

[3]  S. N. Murthy,et al.  Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation , 2009, Peptides.

[4]  K. Finlayson,et al.  VPAC and PAC receptors: From ligands to function. , 2009, Pharmacology & therapeutics.

[5]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[6]  G. Rasi,et al.  PACAP and VIP prevent apoptosis in schwannoma cells , 2008, Brain Research.

[7]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[8]  D. Aronson.  Hyperglycemia and the pathobiology of diabetic complications. , 2008, Advances in cardiology.

[9]  Bin Hu,et al.  VIP inhibits human HepG2 cell proliferation in vitro , 2008, Regulatory Peptides.

[10]  M. Kassem,et al.  Effects of high glucose on mesenchymal stem cell proliferation and differentiation. , 2007, Biochemical and biophysical research communications.

[11]  D. Ribatti,et al.  Nonclassic Endogenous Novel Regulators of Angiogenesis , 2007, Pharmacological Reviews.

[12]  M. Rema,et al.  Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. , 2006, Investigative ophthalmology & visual science.

[13]  N. Klugbauer,et al.  Pituitary Adenylyl Cyclase-activating Polypeptide 38 Reduces Astroglial Proliferation by Inhibiting the GTPase RhoA* , 2005, Journal of Biological Chemistry.

[14]  O. Stenina.  Regulation of vascular genes by glucose. , 2005, Current pharmaceutical design.

[15]  A. Harmar,et al.  Distribution of the VPAC2 receptor in peripheral tissues of the mouse. , 2004, Endocrinology.

[16]  I. Tatsuno,et al.  Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis , 2003, Regulatory Peptides.

[17]  C. R. Larsen,et al.  VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries , 2003, Regulatory Peptides.

[18]  G. King,et al.  Molecular understanding of hyperglycemia's adverse effects for diabetic complications. , 2002, JAMA.

[19]  J. Bockaert,et al.  Up‐regulation of the PACAP type‐1 receptor (PAC1) promoter by neurotrophins in rat PC12 cells and mouse cerebellar granule cells via the Ras/mitogen‐activated protein kinase cascade , 2002, Journal of neurochemistry.

[20]  S. Shioda,et al.  PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. , 2002, Current protein & peptide science.

[21]  L. Edvinsson,et al.  Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia , 2002, Neuroreport.

[22]  M. Brownlee.  Insight Review Articles , 2022 .

[23]  F. Zannad,et al.  Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. , 2001, Diabetes & metabolism.

[24]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[25]  J. Reubi.  In Vitro Evaluation of VIP/PACAP Receptors in Healthy and Diseased Human Tissues: Clinical Implications , 2000, Annals of the New York Academy of Sciences.

[26]  J. Hannibal,et al.  Immunohistochemical Localization of the VIP1 Receptor (VPAC1R) in Rat Cerebral Blood Vessels: Relation to PACAP and VIP Containing Nerves , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Diane M. Jaworski,et al.  Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury , 2000, Cell and Tissue Research.

[28]  W. Qi,et al.  Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells , 1999, Diabetologia.

[29]  A. Arimura.  Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. , 1998, The Japanese journal of physiology.

[30]  W. Wetsel,et al.  Functional Impairment in Protein Kinase C by RACK1 (Receptor for Activated C Kinase 1) Deficiency in Aged Rat Brain Cortex , 1996, Journal of neurochemistry.

[31]  L. Gesualdo,et al.  High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. , 1996, The American journal of pathology.

[32]  G. Striker,et al.  Inhibition of diabetic nephropathy by a GH antagonist: a molecular analysis. , 1996, Kidney international.

[33]  C. Garlanda,et al.  Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Kilo,et al.  Capillary Basement Membranes in Diabetes , 1983, Diabetes.

[35]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.